Sharing Mayo Clinic: 'Sneaky' cancer spurs mom and daughter to action
When Lisa Pitre, a Mayo Clinic speech pathologist from Jacksonville, Florida, went in for a routine mammogram in summer 2019, nothing on her imaging was concerning. By October, though, Lisa was diagnosed with stage 4 invasive lobular carcinoma, an aggressive type of breast cancer. "I learned that 20% of breast cancers are not detected on mammograms, and mine was one of those," says the 53-year-old mother of two, noting that her cancer was found only after an MRI… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 30, 2021 Category: Databases & Libraries Source Type: news

Invasive Lobular Carcinoma: The Importance of This Subtype Invasive Lobular Carcinoma: The Importance of This Subtype
Get up-to-date on the latest research that has advanced our understanding of the pathology and management of this common subtype of breast cancer.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Scientists model a peculiar type of breast cancer
(Ecole Polytechnique F é d é rale de Lausanne) Scientists led by EPFL have developed a breakthrough in vivo model for invasive lobular carcinoma, a serious yet understudied type of breast cancer. The work will open up previously inaccessible study of the tumor's biology and help discover new therapies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 22, 2021 Category: Biology Source Type: news

Gene Signature May Be Similarly Prognostic in ILC and IDC Gene Signature May Be Similarly Prognostic in ILC and IDC
The MammaPrint 70-gene signature has similar prognostic performance in women with early-stage invasive lobular carcinoma and invasive ductal carcinoma (IDC), according to an exploratory analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 20, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Genetic Test Spots High-Risk Invasive Lobular Carcinoma Genetic Test Spots High-Risk Invasive Lobular Carcinoma
A test that looks at the activity of 70 genes in breast tumors can help identify women with invasive lobular carcinoma (ILC) at high-risk of cancer recurrence or progression after surgery who may benefit from additional therapy, according to new research.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 6, 2020 Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news

Genetic test identifies invasive lobular carcinomas that are at high risk of recurring
(European Organisation for Research and Treatment of Cancer) New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 30, 2020 Category: Cancer & Oncology Source Type: news

Emerging From Mastectomy With A Healthy Body Image Intact
For eight years, Margaret Pelikan dreaded mammograms. In 2008, she had been diagnosed with a condition called lobular carcinoma (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 7, 2017 Category: Consumer Health News Source Type: news

Why You Should Always Ask For A Second Opinion
Two years ago, when actress-singer Rita Wilson was 58, she underwent a double mastectomy and had this to say about it: Getting a second opinion saved her life. Wilson was right to insist on a second opinion, according to a Mayo Clinic study released this month. Of 286 patients who sought a second opinion from the clinic over a two-year period, 88 percent received a diagnosis that was either modified or completely different from the first one they received. Sixty-six percent of patients received a refined diagnosis and 22 percent received a completely different one, the study found.  Only 12 percent received confirmati...
Source: Healthy Living - The Huffington Post - April 26, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Invasive lobular carcinoma: Symptoms, subtypes, diagnosis, and treatment
Learn about invasive lobular carcinoma, a type of cancer that starts in the milk glands of the breast and can spread to infect other lymph nodes. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 31, 2017 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Dilon updates Navigator gamma probe
Molecular breast imaging developer Dilon Diagnostics has released a new version...Read more on AuntMinnie.comRelated Reading: Dilon highlights molecular breast tomo device at SNMMI Dilon, GE present breast biopsy tool at SBI Dilon signs distribution deal with GE Dilon touts MBI for invasive lobular carcinoma Dilon: Patient wins legal appeal for MBI coverage (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 7, 2016 Category: Radiology Source Type: news

Dilon highlights molecular breast tomo device at SNMMI
Molecular breast imaging developer Dilon Diagnostics is highlighting new molecular...Read more on AuntMinnie.comRelated Reading: Dilon, GE present breast biopsy tool at SBI Dilon signs distribution deal with GE Dilon touts MBI for invasive lobular carcinoma Dilon: Patient wins legal appeal for MBI coverage Digirad expands relationship with Dilon (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2016 Category: Radiology Source Type: news

Dilon, GE present breast biopsy tool at SBI
Dilon Diagnostics and GE Healthcare will present a breast biopsy localization...Read more on AuntMinnie.comRelated Reading: GE places digital SPECT/CT system in Israel GE joins Santa Clara Univ. on African initiative GE eyes Cuba in wake of historic opening Dilon signs distribution deal with GE Dilon touts MBI for invasive lobular carcinoma Dilon: Patient wins legal appeal for MBI coverage (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 7, 2016 Category: Radiology Source Type: news

Invasive Lobular Carcinoma -- A Distinct Breast Cancer SubtypeInvasive Lobular Carcinoma -- A Distinct Breast Cancer Subtype
Genomic studies have highlighted invasive lobular cancer as a distinct subset of breast cancer, which may lead to new treatment approaches in the future. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 31, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

What Is Breast Cancer Stage Zero?
Is Stage Zero breast cancer really cancer or not? Find out what the staging means for ductal or lobular carcinoma in situ in diagnosis and treatment. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - March 9, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news

Allina Health study could save breast cancer patients time, money and side effects
(Allina Health ) The study was designed to determine the tumor and patient characteristics which predicted lower risk of breast cancer recurrence in women with invasive lobular carcinoma. Classic ILC is more likely to respond to edocrine treatment than chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2015 Category: Cancer & Oncology Source Type: news